FDA advisory panel approves combination weight-loss drug
Links shared publicly online about this topic.
- 672total visits
FDA advisory panel approves combination weight-loss drug
View full resource at endocrinetoday.com
Tags: Metabolic, Antidepressant, Drug, Smoking Cessation Medication, FDA, Wellbutrin, Zyban
Most Recently Shared on December 7, 2010 at 10:17 pm By:
RT @endocrinetoday: #FDA advisory panel approves combination weight-loss drug http://ow.ly/3lwNv
Also Shared By:
Weight loss pill Qnexa wins panel vote and awaits approval
news-medical.net — “The drug was rejected in a 10-6 vote the first time it came before a Food and Drug Administration (FDA) advisory panel, in 2010, due to safety concerns. However when the medication returned for another review in February, the advisory committee gave it near-unanimous approval (20-2). Because the FDA often follows the advisory panel's advice, Qnexa is likely to get FDA approval, probably by mid-April.” View full resource at news-medical.net
Most Recently Shared on April 5, 2012 at 11:08 pm By:
Diet News: Weight loss pill Qnexa wins panel vote and awaits approval: The drug was rejected in a 10-6 vote the ... http://t.co/rGbONdEq
FDA Panel Recommends Approval of Diet Drug Qnexa - ABC News
abcnews.go.com — “A U.S. Food and Drug Administration Advisory Committee today recommended approval of the weight loss drug Qnexa, a treatment many hope will help millions of Americans who struggle with obesity. In voting 20 to 2 for approval, the committee said today that Qnexa’s weight loss benefits for the chronically obese outweighed the risks of birth defects and cardiovascular problems that have been associated with the drug. An FDA advisory panel recommended against approval in 2010 over c” View full resource at abcnews.go.com
Most Recently Shared on February 22, 2012 at 10:28 pm By:
Susan Scroggins Health Advocate and Active Health Library
FDA Panel Recommends Diet Drug Qnexa: A U.S. Food and Drug Administration Advisory Committee today recommended a... http://t.co/opoMeEp8
Trilipix With Statin No Better Than Statin Alone? FDA Panel Meets This Week
medicalnewstoday.com — “Abbott's blockbuster cholesterol drug, Trilipix (fenofibrate), which is taken in combination with a statin was found to be no better at reducing heart attack risk than taking the statin alone, in” View full resource at medicalnewstoday.com
Most Recently Shared on May 18, 2011 at 2:28 am By:
HDCN: FDA advisory panel will convene to reconsider approval of fenofibrate http://bit.ly/mdJ4EN
Big Mistake: FDA Panel Votes To Expand Weight Loss Surgery - Larry Van Horn - Second Opinion - Forbes
blogs.forbes.com — “Last week, a U.S. Food and Drug Administration advisory panel endorsed the expanded use of Lap-Band weight-loss surgery in less-than-the-severely obese. If approved by the full F.D.A. -- as these recommendations usually are -- the number of potential patients eligible for the procedure could double. Okay, where do I start? Not surprisingly [...]” View full resource at blogs.forbes.com
Most Recently Shared on December 10, 2010 at 4:46 pm By:
Drugs and Devices OW OW Health
Big Mistake: Panel Votes To Expand Weight Loss Surgery: Last week, a U.S. Food and Drug Administration adv... http://bit.ly/gi8kUV #drug
New Diet Pill Wins FDA Panel's Backing - Drugs.com MedNews
drugs.com — “An expert advisory panel recommended on Tuesday that Contrave, a new weight-loss pill that combines an antidepressant with an anti-addiction medication, be appr” View full resource at drugs.com
Most Recently Shared on December 8, 2010 at 11:53 pm By:
New Diet Pill Wins FDA Panel's Backing - http://bit.ly/fqD8vp
New Diet Pill Wins FDA Panel's Backing
health.yahoo.net — “TUESDAY, Dec. 7 (HealthDay News) -- An expert advisory panel recommended on Tuesday that Contrave, a new weight-loss pill that combines an antidepressant with an anti-addiction medication, be approved by the U.S. Food and Drug Administration.” View full resource at health.yahoo.net
Most Recently Shared on December 8, 2010 at 2:40 pm By:
New Diet Pill Wins FDA Panel's Backing http://bit.ly/gzagkw
FDA Panel Endorses Contrave Weight-Loss Drug - ABC News
abcnews.go.com — “An FDA advisory committee has voted 13-7 that the modest weight-loss benefits of an investigational combination of naltrexone and bupropion (Contrave) outweigh the drug's blood pressure risk.” View full resource at abcnews.go.com
Most Recently Shared on December 8, 2010 at 1:23 pm By:
Dr. Stephen Sinatra Internist, Cardiologist, Nutritionist, Physician, and Doctor
FDA panel recommends diet pill despite little benefit compared to placebo and real heart risks. Thumbs down! http://ow.ly/3lTsY
Panel Endorses Weight-Loss Drug - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- SILVER SPRING, Md. -- An FDA advisory committee has voted 13-7 that the modest weight-loss benefits of an investigational combination of naltrexone and bupropion (Contrave) outweigh the drug's blood pressure risk.” View full resource at qualitypointtech.net
Most Recently Shared on December 8, 2010 at 3:48 am By:
Panel Endorses Weight-Loss Drug: (MedPage Today) -- SILVER SPRING, Md. -- An FDA advisory committee has voted 13-7... http://bit.ly/fLaZ9R
Medical News: Panel Endorses Weight-Loss Drug - in Primary Care, Obesity from MedPage Today
medpagetoday.com — “SILVER SPRING, Md. -- An FDA advisory committee has voted 13-7 that the modest weight-loss benefits of an investigational combination of naltrexone and bupropion (Contrave) outweigh the drug's blood p” View full resource at medpagetoday.com
Most Recently Shared on December 7, 2010 at 11:46 pm By:
Panel Endorses Weight-Loss Drug http://bit.ly/gsyZA5
Orexigen diet pill wins FDA panel backing | Reuters
reuters.com — “SILVER SPRING, Maryland (Reuters) - U.S. health advisers recommended approval of the first new weight-loss pill in a decade on Tuesday, backing Orexigen Therapeutics Inc's Contrave. It was the last of” View full resource at reuters.com
Most Recently Shared on December 7, 2010 at 10:50 pm By:
Orexigen diet drug wins advisory panel backing http://bit.ly/hP09Y5
Orexigen diet pill wins FDA panel backing | Reuters
reuters.com — “SILVER SPRING, Maryland (Reuters) - U.S. health advisers recommended approval of the first new weight-loss pill in a decade on Tuesday, backing Orexigen Therapeutics Inc's Contrave. It was the last of” View full resource at reuters.com
Most Recently Shared on December 7, 2010 at 9:51 pm By:
Orexigen diet drug wins advisory panel backing http://reut.rs/fnD0ZD
Orexigen Therapeutics: FDA Panel Live Blog - TheStreet
thestreet.com — “Orexigen brings its weight-loss drug Contrave skin in front of an FDA advisory panel today.” View full resource at thestreet.com
Most Recently Shared on December 7, 2010 at 1:13 pm By:
Scott Hensley Health Organization
For a skinny dude, @adamfeuerstein sure is obsessed with diet pills. The $OREX FDA Panel Live Blog is Live! http://bit.ly/gQ2X7a
Lap-Band Recommended For Less Obese Patients By FDA Panel - QualityPoint Technologies
qualitypointtech.net — “An FDA Advisory Panel voted 8 to 2 in favor of approving the weight-loss Lap-Band for use in less obese people than current regulations allow, the FDA (Food and Drug Administration) informs. The Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee determined that the benefits outweigh the risks for less obese patients. The Panel's recommendation is not binding; however, the FDA usually goes along with what it says. If wider usage of the Lap-Band is approved, it wo” View full resource at qualitypointtech.net
Most Recently Shared on December 4, 2010 at 6:47 pm By:
Lap-Band Recommended For Less Obese Patients By FDA Panel: An FDA Advisory Panel voted 8 to 2 in favor of approvin... http://bit.ly/h2UFI7
Lap-Band Recommended For Less Obese Patients By FDA Panel
medicalnewstoday.com — “An FDA Advisory Panel voted 8 to 2 in favor of approving the weight-loss Lap-Band for use in less obese people than current regulations allow, the FDA (Food and Drug Administration) informs. The G” View full resource at medicalnewstoday.com
Most Recently Shared on December 4, 2010 at 6:05 pm By:
Lap-Band Recommended For Less Obese Patients By FDA Panel An FDA Advisory Panel voted 8 to 2 in favor of approving the .. http://dld.bz/9p96
Advertisement
Endocrine Today
@EndocrineToday
#FDA advisory panel approves combination weight-loss drug http://ow.ly/3lwNv
1 year ago...